| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.059 | 0.3 |